Wei Shen Lim, KBE, is a consultant respiratory physician and honorary professor of medicine at Nottingham University Hospitals NHS Trust, England.[1][2]

Lim graduated from University of Nottingham Medical School in 1991 and has been on the specialist register for General Internal Medicine and Respiratory Medicine since 2002.[3] Since November 2020 or earlier, he has been chairman of the COVID-19 subcommittee of the Joint Committee on Vaccination and Immunisation which provides advice to the UK government.[4]

In 2021 and in 2022, he received more than £25,001 in research funding from vaccine-maker Pfizer.[5]

In 2024, Lim was awarded an honorary KBE for services to the COVID-19 vaccination programme.[6]

References

  1. ^ "Our COVID-19 Experts". Nottingham Biomedical Research Centre. Retrieved 3 December 2020.
  2. ^ Lim, Wei Shen; Thomson, Anne; Little, Paul (10 February 2007). "Preparing for the next flu pandemic". BMJ. 334 (7588): 268–269. doi:10.1136/bmj.39101.628715.80. PMC 1796676. PMID 17289687.
  3. ^ "Wei Shen LIM". General Medical Council.
  4. ^ "Coronavirus: Phase one vaccine rollout will protect '99 per cent' of UK's at-risk population". CityAM. 11 November 2020. Retrieved 3 December 2020.
  5. ^ "About Us: Professor Wei Shen Lim". British Thoracic Society. 2022. Archived from the original on 21 November 2022 – via Internet Archive.
  6. ^ "Honorary awards to foreign nationals in 2024". Foreign, Commonwealth & Development Office.


Categories